eMedicine Specialties > Physical Medicine and Rehabilitation > Spinal Cord Injury

Prevention of Thromboembolism in Spinal Cord Injury

Author: Dana McKinney, MD, Assistant Professor, Department of Physical Medicine and Rehabilitation, University of Kansas Medical Center
Coauthor(s): Susan V Garstang, MD, Assistant Professor, Residency Program Director, Department of Physical Medicine and Rehabilitation, University of Medicine and Dentistry of New Jersey; Attending Medical Staff, Director of Spinal Cord Injury Program, Department of Physical Medicine and Rehabilitation, University Hospital
Contributor Information and Disclosures

Updated: Nov 21, 2008

Introduction

Background

Deep vein thrombosis (DVT) and pulmonary embolism (PE) are common complications of acute spinal cord injury (SCI) and a major cause of morbidity and mortality in patients with SCI. Many patients with SCI do not receive DVT prophylaxis in the acute care setting,1 perhaps secondary to concomitant medical problems that may enhance the risk of bleeding. In a retrospective study by Powell and colleagues, 38.6% of patients admitted to a rehabilitation hospital were receiving prophylaxis.2 Clinically apparent DVT occurs in approximately 15% of patients with acute SCI, and PE develops in approximately 5% of these patients. The risk of DVT is highest within the first 2 weeks following injury, with peak occurrence between days 7 and 10. DVT has been detected as early as 72 hours postinjury; however, risk prior to this time appears to be low.

Related eMedicine topics:
Deep Venous Thrombosis
Deep Venous Thrombosis and Thrombophlebitis
Deep Venous Thrombosis, Lower Extremity
Deep Venous Thrombosis Prophylaxis in Orthopedic Surgery
Deep Venous Thrombosis, Upper Extremity
Perioperative DVT Prophylaxis
Pulmonary Embolism [Emergency Medicine]
Pulmonary Embolism [Pulmonology]
Spinal Cord Injuries
Spinal Cord Injury: Definition, Epidemiology, Pathophysiology
Spinal Cord Trauma and Related Diseases
Thromboembolism [Orthopedic Surgery]
Thromboembolism [Pediatrics: General Medicine]

Pathophysiology

Predisposing risk factors for the development of deep vein thrombosis (DVT) following spinal cord injury (SCI) are found in the Virchow triad (ie, venous stasis, hypercoagulable state, endothelial injury). Venous stasis results from loss of the pumping function normally provided by contracting limb muscles. Hypercoagulability result from the stimulation of thrombogenic factors following injury, with a resultant increase in platelet aggregation and adhesion. Intimal injury may occur directly, from vasoactive amines released in association with trauma or surgery, or it may result indirectly, from external pressure on the paralyzed leg.

Patients with DVT have higher levels of von Willebrand factor antigen and factor VIII–related antigen than do patients without thrombosis, and they demonstrate hyperactive platelet aggregation responses to collagen and the appearance of circulating platelet aggregates.

Clinical factors believed to be associated with DVT include motor complete injuries, paraplegia, and male gender.3 In the study by Powell and colleagues, no statistical difference in the incidence of DVT was found between patients with a motor complete injury and those with a motor incomplete injury, between patients with tetraplegia and those with paraplegia, or between patients with a traumatic cause of SCI and those with a nontraumatic cause.2 Thus, all patients with SCI are at risk of developing a DVT.

Related eMedicine topics:
Factor VIII
von Willebrand Disease [Hematology]
Von Willebrand Disease [Pediatrics: General Medicine]

Frequency

United States

In prospective studies, the incidence of deep vein thrombosis (DVT) following acute spinal cord injury (SCI) has been reported at 18-100%, depending on the diagnostic technique used, time after SCI, and concurrent risk factors. Overall incidence without prophylaxis is estimated to be 40% based on the meta-analysis of DVT in patients with acute SCI. Clinically apparent DVT occurs in approximately 15% of patients with acute SCI, and PE develops in approximately 5% of acute SCI cases.

Mortality/Morbidity

Because of the high incidence of thromboembolic disease in patients with acute spinal cord injury and owing to the potential morbidity and mortality associated with this disease, the use of effective prophylactic measures is of great importance. Morbidities from DVT include postphlebitic syndrome, prolonged edema, and pressure ulcers. Pulmonary embolisms can cause arrhythmias, hypoxia, and death.

Sex

A higher prevalence has been noted in males.

Age

No age prevalence has been found for deep vein thrombosis.

Clinical

History

In patients with spinal cord injury (SCI), clinical diagnostic signs and symptoms may differ from those found in noninjured patients and may be much more difficult to identify. The characteristics and diagnostic value of various clinical signs and symptoms are as follows:

  • Leg swelling
    • Typically, the hallmark of deep vein thrombosis (DVT) is a rapid onset of unilateral leg swelling.
    • Swelling of the lower extremities may be bilateral.
    • Edema may be the only presenting symptom.
  • Leg pain
    • This symptom is nonspecific and includes a vast differential diagnosis.
    • Leg pain generally is not a useful diagnostic symptom in patients with insensate lower extremities following SCI.
  • The clinical signs and symptoms of pulmonary embolism may be the primary manifestation in patients with confirmed DVT. Symptoms may include pleuritic chest pain, dyspnea, hemoptysis, and feelings of impending doom.

Physical

Overall, the diagnostic properties of the clinical examination are poor. Clinical findings are absent in 50% of patients with confirmed deep vein thrombosis (DVT). However, although it is virtually impossible to distinguish DVT from other processes, the following findings should raise clinical suspicion:

  • Leg swelling
    • Principally unilateral, but may be bilateral
    • Circumferential increase of the affected leg by at least 3 cm
  • Tenderness on compression of the calf muscles or over the course of the deep veins in the thigh
  • Increased temperature over the calf or thigh
  • Pain during forced dorsiflexion of the foot (Homan sign), a nonspecific and insensitive test
  • Low-grade fever that cannot be explained after investigation of other possible sources
  • Superficial thrombophlebitis felt as a palpable cord and/or superficial venous distension at the knee, groin, or anterior abdominal wall
  • As stated before, clinical signs and symptoms of pulmonary embolism (PE) may be the primary manifestation in patients with confirmed DVT. Further physical signs of PE may include the following:
    • Tachycardia
    • Tachypnea
    • Hypoxia
    • Change in mental status
    • Pleural friction rub
    • Fever
    • Cyanosis
    • Rales
    • Pleural effusion

Causes

Patients with spinal cord injury (SCI) have a higher risk of thromboembolic disease related to the Virchow triad (ie, venous stasis, hypercoagulability, intimal injury). Stasis from paralyzed muscles and hypercoagulability remain the 2 major factors contributing to the development of thrombosis in this patient population. Other common risk factors for venous thromboembolism include the following:

  • Immobilization - The muscles in the legs act as pumps to maintain venous return from the lower extremities. Inactivity of these muscles leads to venous stasis.
  • Advanced age
  • Congestive heart failure - Cardiac output is reduced, as is venous return from the legs.
  • Prior venous thromboembolism
  • Surgical procedure of lower extremity/pelvis
  • Cancer/malignancy
  • Oral contraceptive use/pregnancy
  • Trauma (eg, multiple trauma, SCI, burns, lower extremity fractures) - Direct mechanical injury to the lower extremities may lead to blood clot formation.

More on Prevention of Thromboembolism in Spinal Cord Injury

Overview: Prevention of Thromboembolism in Spinal Cord Injury
Differential Diagnoses & Workup: Prevention of Thromboembolism in Spinal Cord Injury
Treatment & Medication: Prevention of Thromboembolism in Spinal Cord Injury
Follow-up: Prevention of Thromboembolism in Spinal Cord Injury
References

References

  1. Yu HT, Dylan ML, Lin J, et al. Hospitals' compliance with prophylaxis guidelines for venous thromboembolism. Am J Health Syst Pharm. Jan 1 2007;64(1):69-76. [Medline].

  2. Powell M, Kirshblum S, O'Connor KC. Duplex ultrasound screening for deep vein thrombosis in spinal cord injured patients at rehabilitation admission. Arch Phys Med Rehabil. Sep 1999;80(9):1044-6. [Medline].

  3. Jones T, Ugalde V, Franks P, et al. Venous thromboembolism after spinal cord injury: incidence, time course, and associated risk factors in 16,240 adults and children. Arch Phys Med Rehabil. Dec 2005;86(12):2240-7. [Medline].

  4. Akers SM, Bartter T, Pratter MR. Impedance plethysmography. It's the clinical outcome that counts. Chest. Nov 1994;106(5):1317-8. [Medline][Full Text].

  5. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. Jun 2008;133(6 Suppl):381S-453S. [Medline].

  6. Green D. Prophylaxis of thromboembolism in spinal cord-injured patients. Chest. Dec 1992;102(6 Suppl):649S-651S. [Medline][Full Text].

  7. Clagett GP, Anderson FA, Geerts W, et al. Prevention of venous thromboembolism. Chest. Nov 1998;114(5 Suppl):531S-560S. [Medline][Full Text].

  8. Clagett GP, Anderson FA, Heit J, et al. Prevention of venous thromboembolism. Chest. Oct 1995;108(4 Suppl):312S-334S. [Medline][Full Text].

  9. Geerts WH, Jay RM, Code KI, et al. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med. Sep 5 1996;335(10):701-7. [Medline][Full Text].

  10. Green D, Lee MY, Lim AC, et al. Prevention of thromboembolism after spinal cord injury using low-molecular-weight heparin. Ann Intern Med. Oct 15 1990;113(8):571-4. [Medline].

  11. Shackford SR, Cook A, Rogers FB, et al. The increasing use of vena cava filters in adult trauma victims: data from the American College of Surgeons National Trauma Data Bank. J Trauma. Oct 2007;63(4):764-9. [Medline].

  12. Burns SP, Nelson AL, Bosshart HT, et al. Implementation of clinical practice guidelines for prevention of thromboembolism in spinal cord injury. J Spinal Cord Med. 2005;28(1):33-42. [Medline].

  13. Consortium for Spinal Cord Medicine Clinical Practice Guidelines. Prevention of Thromboembolism in Spinal Cord Injury. 2nd ed. Washington, DC: Paralyzed Veterans of America; 1999.

  14. Hebbeler SL, Marciniak CM, Crandall S, et al. Daily vs twice daily enoxaparin in the prevention of venous thromboembolic disorders during rehabilitation following acute spinal cord injury. J Spinal Cord Med. 2004;27(3):236-40. [Medline].

  15. Slavik RS, Chan E, Gorman SK, et al. Dalteparin versus enoxaparin for venous thromboembolism prophylaxis in acute spinal cord injury and major orthopedic trauma patients: 'DETECT' trial. J Trauma. May 2007;62(5):1075-81; discussion 1081. [Medline].

  16. Worley S, Short C, Pike J, et al. Dalteparin vs low-dose unfractionated heparin for prophylaxis against clinically evident venous thromboembolism in acute traumatic spinal cord injury: a retrospective cohort study. J Spinal Cord Med. 2008;31(4):379-87. [Medline].

  17. Anand SS, Wells PS, Hunt D, et al. Does this patient have deep vein thrombosis?. JAMA. Apr 8 1998;279(14):1094-9. [Medline].

  18. Green D, Rossi EC, Yao JS, et al. Deep vein thrombosis in spinal cord injury: effect of prophylaxis with calf compression, aspirin, and dipyridamole. Paraplegia. Aug 1982;20(4):227-34. [Medline].

  19. Green D, Sullivan S, Simpson J, et al. Evolving risk for thromboembolism in spinal cord injury (SPIRATE Study). Am J Phys Med Rehabil. Jun 2005;84(6):420-2. [Medline].

  20. Merli GJ, Crabbe S, Doyle L, et al. Mechanical plus pharmacological prophylaxis for deep vein thrombosis in acute spinal cord injury. Paraplegia. Aug 1992;30(8):558-62. [Medline].

  21. Merli GJ, Crabbe S, Paluzzi RG, et al. Etiology, incidence, and prevention of deep vein thrombosis in acute spinal cord injury. Arch Phys Med Rehabil. Nov 1993;74(11):1199-205. [Medline].

Further Reading

Keywords

deep venous thrombosis, embolism, DVT, pulmonary embolism, spinal cord injury, clot, blood clot, blood clots, paralysis, spinal cord, spinal, platelet, platelets, thromboembolism, vein thrombosis, deep vein thrombosis, venous thrombosis, anticoagulation, paraplegia, thromboembolic disease, vein thrombosis treatment, venous thrombosis treatment

Contributor Information and Disclosures

Author

Dana McKinney, MD, Assistant Professor, Department of Physical Medicine and Rehabilitation, University of Kansas Medical Center
Dana McKinney, MD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, American Paraplegia Society, and National Medical Association
Disclosure: Nothing to disclose.

Coauthor(s)

Susan V Garstang, MD, Assistant Professor, Residency Program Director, Department of Physical Medicine and Rehabilitation, University of Medicine and Dentistry of New Jersey; Attending Medical Staff, Director of Spinal Cord Injury Program, Department of Physical Medicine and Rehabilitation, University Hospital
Susan V Garstang, MD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation and Association of Academic Physiatrists
Disclosure: Nothing to disclose.

Medical Editor

Milton J Klein, DO, MBA, Consulting Physiatrist, Sewickley Valley Hospital, Allegheny General Hospital, Harmarville Rehabilitation Center, Ohio Valley General Hospital, and Aliquippa Community Hospital
Milton J Klein, DO, MBA is a member of the following medical societies: American Academy of Disability Evaluating Physicians, American Academy of Medical Acupuncture, American Academy of Osteopathy, American Academy of Physical Medicine and Rehabilitation, American Medical Association, American Osteopathic Association, American Osteopathic College of Physical Medicine and Rehabilitation, American Pain Society, and Pennsylvania Medical Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Kat Kolaski, MD, Assistant Professor, Departments of Orthopedic Surgery and Pediatrics, Wake Forest University School of Medicine
Kat Kolaski, MD is a member of the following medical societies: American Academy for Cerebral Palsy and Developmental Medicine and American Academy of Physical Medicine and Rehabilitation
Disclosure: Nothing to disclose.

CME Editor

Kelly L Allen, MD, Regional Medical Director, IMX-Medical Management Services
Disclosure: Nothing to disclose.

Chief Editor

Denise I Campagnolo, MD, MS, Director of Multiple Sclerosis Clinical Research and Staff Physiatrist, Barrow Neurology Clinics, St Joseph's Hospital and Medical Center; Investigator for Barrow Neurology Clinics; Director, NARCOMS Project for Consortium of MS Centers
Denise I Campagnolo, MD, MS is a member of the following medical societies: Alpha Omega Alpha, American Association of Neuromuscular and Electrodiagnostic Medicine, American Paraplegia Society, Association of Academic Physiatrists, and Consortium of Multiple Sclerosis Centers
Disclosure: Teva Neuroscience Honoraria Speaking and teaching; Serono-Pfizer Honoraria Speaking and teaching

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.